NeuroOne Medical Technologies

NMTC · NASDAQ

$0.9838−$0.0162 (−1.62%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $1.00

Latest news

Press releaseOct 8, 4:01 PM ETGlobe Newswire
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
Press releaseOct 5, 9:17 AM ETGlobe Newswire
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
Press releaseSep 17, 9:05 AM ETGlobe Newswire
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
NewsMay 19, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsMay 12, 11:46 AM ET
NeuroOne Medical Tech Q2 2026 Earnings Call Transcript
NewsMay 12, 7:11 AM ET
Earnings Scheduled For May 12, 2026
Press releaseMar 5, 9:00 AM ETPRNewswire
Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments
NewsMar 3, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsFeb 17, 8:02 AM ET
Insights into NeuroOne Medical Tech Q1 Earnings
NewsFeb 17, 8:01 AM ET
NeuroOne Medical Tech Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $2.893M Beat $2.678M Estimate
NewsFeb 17, 6:11 AM ET
Earnings Scheduled For February 17, 2026
NewsFeb 16, 4:01 PM ET
What to Expect from NeuroOne Medical Tech's Earnings
NewsDec 22, 4:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseSep 8, 4:05 PM ETGlobe Newswire
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
Press releaseAug 18, 8:30 AM ETGlobe Newswire
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
Press releaseAug 14, 7:30 AM ETGlobe Newswire
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
NewsAug 14, 4:32 AM ET
Earnings Scheduled For August 14, 2025
Press releaseJul 23, 8:30 AM ETGlobe Newswire
NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office
Press releaseJun 23, 8:30 AM ETGlobe Newswire
NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System
Press releaseJun 3, 8:30 AM ETGlobe Newswire
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
Press releaseMay 13, 7:30 AM ETGlobe Newswire
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
Press releaseApr 23, 9:00 AM ETGlobe Newswire
NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
Press releaseApr 14, 9:00 AM ETGlobe Newswire
NeuroOne® OneRF® Technology Success Story Featured on Fox News
NewsApr 4, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsApr 4, 12:57 PM ETAvi Kapoor
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet
NewsApr 4, 9:53 AM ETAvi Kapoor
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology

NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement

12 Health Care Stocks Moving In Tuesday's After-Market Session

NeuroOne Medical Tech Q2 2026 Earnings Call Transcript

Earnings Scheduled For May 12, 2026

Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments

12 Health Care Stocks Moving In Tuesday's Intraday Session

Insights into NeuroOne Medical Tech Q1 Earnings

NeuroOne Medical Tech Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $2.893M Beat $2.678M Estimate

Earnings Scheduled For February 17, 2026

What to Expect from NeuroOne Medical Tech's Earnings

12 Health Care Stocks Moving In Monday's After-Market Session

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

Earnings Scheduled For August 14, 2025

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® OneRF® Technology Success Story Featured on Fox News

12 Health Care Stocks Moving In Friday's Intraday Session

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March